Produkty 10312-45-5

CAS 10312-45-5 występuje w naszej ofercie pod nazwami: Testosterone Hexanoate, >95% (HPLC), Testosterone Enantate EP Impurity B, Testosterone caproate. Oferty producentów: TRC, Mikromol, Biosynth. Dostępne opakowania: 100mg, 250mg, 25mg, 10mg, 50mg.

Testosterone Hexanoate, >95% (HPLC)
TRC
  • opakowanie: 100mg, 250mg, 25mg
  • Warianty: 3
Zobacz produkt
Testosterone Enantate EP Impurity B
Mikromol
  • opakowanie: 25mg, 100mg
  • Warianty: 2
Zobacz produkt
Testosterone caproate
Biosynth
  • opakowanie: 10mg, 25mg, 50mg, 250mg
  • Warianty: 5
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] hexanoate (CAS 10312-45-5) to związek chemiczny o wzorze sumarycznym C25H38O3 i masie molowej 386.6 g/mol. Nazwa systematyczna IUPAC: [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] hexanoate. InChIKey: WIGTZVOQGIFMAV-BKWLFHPQSA-N.

Dane identyfikacyjne
Wzór sumarycznyC25H38O3
Masa molowa386.6 g/mol
Nazwa IUPAC[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] hexanoate
InChIKeyWIGTZVOQGIFMAV-BKWLFHPQSA-N
SMILESCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Testosterone Caproate, TESTOSTERONE HEXANOATE, 17beta-Hydroxyandrost-4-en-3-one hexanoate, TESTOSTERONE, HEXANOATE, TESTOSTERONE CAPROATE [WHO-DD], TESTOSTERONE CAPRYLATE [NFLIS-DRUG], TESTOSTERONE ENANTATE IMPURITY B [EP IMPURITY], TESTOSTERONE CAPRYLATE (NFLIS-DRUG), TESTOSTERONE ENANTATE IMPURITY B (EP IMPURITY), Androst-4-en-3-one, 17-((1-oxohexyl)oxy)-, (17beta)-
Izomery (ten sam wzór sumaryczny)
(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol C25H38O3
3-[(3E,7E)-4,8-dimethyl-10-(2,6,6-trimethylcyclohexen-1-yl)deca-3,7-dienyl]-2-hydroxy-2H-furan-5-one C25H38O3
(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol C25H38O3
[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] 4-methylpentanoate C25H38O3
(1R,3S,4R,7S,8E,11S,12R)-4-hydroxy-1,4-dimethyl-12-[(2S)-6-methylhept-5-en-2-yl]-6-oxotricyclo[9.3.0.03,7]tetradec-8-ene-8-carbaldehyde C25H38O3
(1S,3R,6R,7S,9E,13S,15R,16S)-3,15-dimethyl-6-[(2S,3Z)-6-methylhepta-3,5-dien-2-yl]-12-oxatetracyclo[8.5.1.03,7.013,16]hexadec-9-ene-13,15-diol C25H38O3
(2S,3S,3aR,5aS,9aS,9bR)-3-[(2S)-2-(furan-3-yl)-2-hydroxyethyl]-2,3a,6,6,9a-pentamethyl-3,4,5,5a,7,8,9,9b-octahydro-1H-cyclopenta[a]naphthalene-2-carbaldehyde C25H38O3
(3S,4R,5R,10S,13R,14R,17R)-3-hydroxy-17-[(2S)-1-hydroxypropan-2-yl]-4,10,13,14-tetramethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthrene-4-carbaldehyde C25H38O3
(3R,4R,5R,10S,13R,14R,17R)-3-hydroxy-17-[(2S)-1-hydroxypropan-2-yl]-4,10,13,14-tetramethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthrene-4-carbaldehyde C25H38O3
(6R,8R,9S,13S,14S,17S)-6-(6-methoxyhexyl)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol C25H38O3